Serum proteomics with SELDI-TOF-MS in congenital human cytomegalovirus hepatitis

Journal of Medical Virology

Volumn 79, Issue 10, 2007, Pages 1500-1505

  Liu, Zhijun ^a   Tian, Ying ^a   Wang, Bin ^a,b   Yan, Zhiyong ^a   Qian, Dongmeng ^a   Ding, Shouyi ^a   Song, Xuxia ^a   Bai, Zhiqiang ^a   Li, Ling ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^b QINGDAO UNIVERSITY   (China)

Author keywords

Congenital cytomegalovirus infection; Neonatal hepatitis syndrome; Proteomics; Surface enhanced laser desorption ionization time of flight mass spectrometry

Indexed keywords

BETA DEFENSIN; BIOLOGICAL MARKER; CYTOKINE; HAPTOGLOBIN; MACROPHAGE DERIVED CHEMOKINE; PREALBUMIN;

ARTICLE; CONTROLLED STUDY; DATA BASE; HEPATITIS; HUMAN; HUMAN CYTOMEGALOVIRUS; INFANT; LIVER FUNCTION; LIVER REGENERATION; MAJOR CLINICAL STUDY; PATHOGENESIS; PROTEIN EXPRESSION; PROTEOMICS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; UPREGULATION;

BETA-DEFENSINS; BLOOD PROTEINS; CHEMOKINES; CYTOCHROME REDUCTASES; CYTOMEGALOVIRUS INFECTIONS; HAPTOGLOBINS; HEPATITIS, VIRAL, HUMAN; HUMANS; INFANT; MACROPHAGES; MOLECULAR WEIGHT; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 34548216804     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20927     Document Type: Article

References (38)

1. Adam BL, Vlahou A, Semmes OJ, Wright GL, Jr. 2001. Proteomic approaches to biomarker discovery in prostate and bladder cancers. Proteomics 1:1264-1270.
2. Alford CA, Britt WJ. 1990. Cytomegalovirus. In: Fields BN, Knipe DM, editors. Virolgy, 2nd edition. New York: Raven Press. pp 1981-2010.
3. Austen BM, Frears ER, Davies H. 2000. The use of seldi proteinchip arrays to monitor production of Alzheimer's betaamyloid in transfected cells. J Pept Sci 6:459-469.
4. Baskar JF, Furnari B, Huang ES. 1993. Demonstration of developmental anomalies in mouse fetuses by transfer of murine cytomegalovirus DNA-injected eggs to surrogate mothers. J Infect Dis 167:1288-1295.
5. Beck S, Barrell BG. 1988. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature 331:269-272.
6. Becker Y, Darai G, Huang E-S, editors. 1993. Molecular aspects of human cytomegalovirus diseases. Berlin: Springer-Verlag.
7. Benirschke K, Kaufmann P. 2000. Pathology of the human placenta. New York: Springer.
8. Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ. 2001. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 344:1366-1371.
9. Brown MR. 1999. 7th Biennial International Forum On Ovarian Cancer, Stockholm, Sweden. 18-21.
10. Cazares LH, Adam BL, Ward MD, Nasim S, Schellhammer PF, Semmes OJ, Wright GL, Jr. 2002. Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry. Clin Cancer Res 8:2541-2552.
11. Chong BE, Hamler RL, Lubman DM, Ethier SP, Rosenspire AJ, Miller FR. 2001. Differential screening and mass mapping of proteins from premalignant and cancer cell lines using nonporous reversed-phase HPLC coupled with mass spectrometric analysis. Anal Chem 73:1219-1227.
12. Davis GL, Hawrisiak MM. 1977. Experimental cytomegalovirus infection and the developing mouse inner ear: In vivo and in vitro studies. Lab Invest 37:20-29.
13. Ferrari L, Seraglia R, Rossi CR, Bertazzo A, Lise M, Allegri G, Traldi P. 2000. Protein profiles in sera of patients with malignant cutaneous melanoma. AT Rapid Commun Mass Spectrom 14:1149-1154.
14. Fitzgerald NA, Papadimitriou JM, Shellam GR. 1990. Cytomegalovirus- induced pneumonitis and myocarditis in newborn mice. A model for perinatal human cytomegalovirus infection. Arch Virol 115:75-88.
15. Gaytant MA, Steegers EA, Semmekrot BA, Merkus HM, Galama JM. 2002. Congenital cytomegalovirus infection: Review of the epidemiology and outcome. Obstet Gynecol Surv 57:245-256.
16. Hampel DJ, Sansome C, Sha M, Brodsky S, Lawson WE, Goligorsky MS. 2001. Toward proteomics in uroscopy: Urinary protein profiles after radiocontrast medium administration. J Am Soc Nephrol 12:1026-1035.
17. Isom HC, Yin CY. 1990. Guinea pig cytomegalovirus gene expression. Curr Top Microbiol Immunol 154:101-121.
18. Jr GW, Cazares LH, Leung SM, Nasim S, Adam BL, Yip TT, Schellhammer PF, Gong L, Vlahou A. 1999. Proteinchip(R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry: A novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer Prostatic Dis 2:264-276.
19. Keough T, Lacey MP, Fieno AM, Grant RA, Sun Y, Bauer MD, Begley KB. 2000. Tandem mass spectrometry methods for definitive protein identification in proteomics research. Electrophoresis 21:2252-2265.
20. Koopmann J, Zhang Z, White N, Rosenzweig J, Fedarko N, Jagannath S, Canto MI, Yeo CJ, Chan DW, Goggins M. 2004. Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry. Clin Cancer Res 10:860-868.
21. Landolfo S, Gariglio M, Gribaudo G, Lembo D. 2003. The human cytomegalovirus. Pharmacol Ther 98:269-297.
22. Maidji E, McDonagh S, Genbacev O, Tabata T, Pereira L. 2006. Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis. Am J Pathol 168:1210-1226.
23. McDonagh S, Maidji E, Chang HT, Pereira L. 2006. Patterns of human cytomegalovirus infection in term placentas: A preliminary analysis. J Clin Virol 35:210-215.
24. Merchant M, Weinberger SR. 2000. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 21:1164-1177.
25. Mocarski ES, Jr., Abenes GB, Manning WC, Sambucetti LC, Cherrington JM. 1990. Molecular genetic analysis of cytomegalovirus gene regulation in growth, persistence and latency. Curr Top Microbiol Immunol 154:47-74.
26. Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S. 2006. Congenital cytomegalovirus infection following first trimester maternal infection: Symptoms at birth and outcome. J Clin Virol 35:216-220.
27. Paweletz CP, Liotta LA, Petricoin EF III. 2001. New technologies for biomarker analysis of prostate cancer progression: Laser capture microdissection and tissue proteomics. Urology 57:160-163.
28. Pignatelli S, Dal Monte P, Rossini G, Landini MP. 2004. Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains. Rev Med Virol 14:383-410.
29. Revello MG, Gerna G. 2002. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 15:680-715.
30. Srinivas PR, Srivastava S, Hanash S, Wright GL, Jr. 2001. Proteomics in early detection of cancer. Clin Chem 47:1901-1911.
31. Stinski M. 1990. Cytomegalovirus and its replication. In: Fields BN, Knipe DM, editors. Virology, 2nd edition. New York: Raven Press, pp 1959-1980.
32. Tsutsui Y, Kosugi I, Kawasaki H. 2005. Neuropathogenesis in cytomegalovirus infection: Indication of the mechanisms using mouse models. Rev Med Virol 15:327-345.
33. Varnum SM, Streblow DN, Monroe ME, Smith P, Auberry KJ, Pasa-Tolic L, Wang D, Camp DGII, Rodland K, Wiley S, Britt W, Shenk T, Smith RD, Nelson JA. 2004. Identification of proteins in human cytomegalovirus (HCMV) particles: The HCMV proteome. J Virol 78:10960-10966.
34. Vlahou A, Schellhammer PF, Mendrinos S, Patel K, Kondylis FI, Gong L, Nasim S, Wright GL, Jr. 2001. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am J Pathol 158:1491-1502.
35. von Eggeling F, Junker K, Fiedle W, Wollscheid V, Durst M, Claussen U, Ernst G. 2001. Mass spectrometry meets chip technology: A new proteomic tool in cancer research? Electrophoresis 22:2898-2902.
36. Wen LZ, Xing W, Liu LQ, Ao LM, Chen SH, Zeng WJ. 2002. Cytomegalovirus infection in pregnancy. Int J Gynaecol Obstet 79:111-116.
37. Wulfkuhle JD, McLean KC, Paweletz CP, Sgroi DC, Trock BJ, Steeg PS, Petricoin EF III. 2001. New approaches to proteomic analysis of breast cancer. Proteomics 1:1205-1215.
38. Zhou Y, Fisher SJ, Janatpour M, Genbacev O, Dejana E, Wheelock M, Damsky CH. 1997. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 99:2139-2151.